Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-12-017923
Filing Date
2012-03-28
Accepted
2012-03-28 17:56:31
Documents
1
Period of Report
2011-09-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4165
  Complete submission text file 0001140361-12-017923.txt   5557
Mailing Address BECK SCIENCE CENTER 8 HARTOM STREET, HAR HOTZVIM JERUSALEM L3 97775
Business Address BECK SCIENCE CENTER 8 HARTOM STREET, HAR HOTZVIM JERUSALEM L3 97775 972-2-548-6555
BIOCANCELL THERAPEUTICS INC. (Issuer) CIK: 0001451980 (see all company filings)

EIN.: 204630076 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIOCANCELL THERAPEUTICS, INC. 8 HARTOM ST. JERUSALEM L3 97775
Business Address
Burgin Jonathan (Reporting) CIK: 0001519448 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-53708 | Film No.: 12721813